Chairman of the Board, Interim President & Chief Executive Officer
Mr. Cataford was appointed Titan’s Interim President & CEO on June 1, 2023. He had served as Titan’s Interim President & CEO from December 1, 2021 to June 30, 2022. He also serves as CFO, Corporate Secretary & Board Director at Loop Energy, and as Executive Director of Business Link AB. Prior to these roles he was the CEO and co-founder of Zephyr Sleep Technologies Inc., a medical device company specializing in the treatment and diagnoses of sleep-disordered breathing.
He brings significant finance, strategy, board governance and technology company experience to Titan Medical’s board and has served as independent corporate director on a number of public boards of directors at companies listed on the TSX, Nasdaq and TSXV including: Loop Energy Inc. (TSX); Sierra Wireless, Inc. (TSX/NASDAQ), Trakopolis IoT Corp. (TSXV), SemiBioSys Genetics Inc. (TSX), and AGJunction Inc. (TSX) Mr. Cataford has a Bachelor of Science degree in Mechanical Engineering from Queen’s University, an MBA specializing in Finance from Schulich School of Business at York University, and is a graduate of the Institute of Corporate Directors – Directors College, Rotman School of Business at the University of Toronto.
Chief Financial Officer
Mr. Huang is a financial executive with over 20 years of experience developing and implementing financial models and systems, and accounting practices to support the achievement of strategic corporate objectives.
Mr. Huang has strong expertise in evaluating investment opportunities and long-term value creation as well as extensive knowledge of IFRS and U.S. GAAP reporting requirements. Most recently, he served as Senior Vice President, Corporate Finance at Quarterhill Inc., where he led the finance systems migration and reorganized key business processes, streamlining external reporting processes. Prior to Quarterhill, Mr. Huang served as Vice President, Finance at Aralez Pharmaceuticals, responsible for implementing systems upgrades, negotiating potential divestitures and advising on private equity financing. Prior to this, Mr. Huang was Senior Director, Finance at Astellas Pharma. Mr. Huang holds a Bachelor of Science in Physiology from the University of Toronto, a Graduate Diploma in Public Accountancy from McGill University, and has Chartered Accountant Designation.